Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus

MLA

Duan,Fangfang, et al. Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1265081412&authtype=sso&custid=ns315887.

APA

Duan,Fangfang, Song,Chenge, Ma,Yuyu, Jiang,Kuikui, Xu,Fei, Bi,Xiwen, Huang,Jiajia, Hong,Ruoxi, Huang,Zhangzan, Lu,Qianyi, Yuan,Zhongyu, Wang,Shusen, & Xia,Wen. (2021). Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus.

Chicago

Duan,Fangfang, Song,Chenge, Ma,Yuyu, Jiang,Kuikui, Xu,Fei, Bi,Xiwen, Huang,Jiajia, et al. 2021. “Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1265081412&authtype=sso&custid=ns315887.